Estrategias Combinadas en Inmunoterapia Traslacional
ITC
University of Washington School of Medicine
Seattle, Estados UnidosPublications en collaboration avec des chercheurs de University of Washington School of Medicine (1)
2017
-
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
The Lancet, Vol. 389, Núm. 10064, pp. 67-76